0.42
Precedente Chiudi:
$0.3818
Aprire:
$0.39
Volume 24 ore:
1.10M
Relative Volume:
0.79
Capitalizzazione di mercato:
$22.60M
Reddito:
-
Utile/perdita netta:
$-563.30K
Rapporto P/E:
-2.1042
EPS:
-0.1996
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
+7.80%
1M Prestazione:
-4.61%
6M Prestazione:
-15.37%
1 anno Prestazione:
-56.02%
Promis Neurosciences Inc Stock (PMN) Company Profile
Nome
Promis Neurosciences Inc
Settore
Industria
Telefono
416-847-6898
Indirizzo
SUITE 200, 1920 YONGE STREET, TORONTO
Confronta PMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PMN
Promis Neurosciences Inc
|
0.42 | 20.55M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
Promis Neurosciences (NASDAQ:PMN) Earns Buy Rating from HC Wainwright - Defense World
HC Wainwright & Co. Reiterates ProMIS Neurosciences (PMN) Buy Recommendation - Nasdaq
PMN: HC Wainwright & Co. Reiterates Buy Rating with Unchanged Pr - GuruFocus
What sentiment indicators say about ProMIS Neurosciences Inc. stock - newser.com
Will ProMIS Neurosciences Inc. stock gain from strong economyJuly 2025 Price Swings & High Return Trade Guides - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock hit Wall Street targetsMarket Trend Summary & Verified Swing Trading Watchlists - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock beat value stocksMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Will ProMIS Neurosciences Inc. stock outperform Nasdaq indexEarnings Beat & Free Weekly Watchlist of Top Performers - newser.com
Why analysts raise outlook for ProMIS Neurosciences Inc. (23J0) stockJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
How ProMIS Neurosciences Inc. stock responds to policy changesRate Cut & Weekly Chart Analysis and Trade Guides - newser.com
Will ProMIS Neurosciences Inc. stock split again soonWeekly Investment Summary & Real-Time Market Sentiment Reports - newser.com
Can ProMIS Neurosciences Inc. stock sustain institutional interest2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
ProMIS Neurosciences Approves Key Shareholder Proposals - MSN
How strong is ProMIS Neurosciences Inc. (23J0) stock earnings growthQuarterly Investment Review & AI Enhanced Execution Alerts - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock sustain bullish trend into 2025Portfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
ProMIS Neurosciences shareholders approve share consolidation proposal By Investing.com - Investing.com Australia
ProMIS Neurosciences shareholders approve share consolidation proposal - Investing.com
Can ProMIS Neurosciences Inc. (23J0) stock sustain margin levelsQuarterly Portfolio Review & Fast Gain Stock Tips - newser.com
Why retail investors pile into ProMIS Neurosciences Inc. stockRecession Risk & Verified Chart Pattern Trade Signals - newser.com
Why ProMIS Neurosciences Inc. (23J0) stock is a strong analyst pick - newser.com
How ProMIS Neurosciences Inc. stock compares to industry benchmarksEarnings Summary Report & Daily Stock Momentum Reports - newser.com
ProMIS Neurosciences Inc. stock retracement – recovery analysis2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Real time scanner hits for ProMIS Neurosciences Inc. explainedJuly 2025 Action & Target Return Focused Picks - newser.com
Guggenheim Maintains ProMIS Neurosciences (PMN) Buy Recommendation - Nasdaq
Promis Neurosciences Inc Azioni (PMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):